Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
treatment respectively. In line with these data, C26 cells also showed a significant increase in CFP/<br />
YFP ratio following docetaxel treatment (a ratio of 1.0 before and 1.3 and 1.7 after 20 and 48 hours<br />
of docetaxel treatment respectively) (Fig.3B). To confirm our FRET results, we also performed<br />
fluorescence lifetime imaging microscopy (FLIM) (Fig.3C). Caspase-3 activation results in loss of<br />
FRET due to cleavage of the DEVD motif (Fig.2A) and therefore should cause an increase in the CFP<br />
fluorescence lifetime 610 . In line with our CFP/YFP ratio measurements, FLIM analysis of C26 cells after<br />
docetaxel treatment revealed a significant increase in CFP lifetime from, on average, 1.3 ns before<br />
docetaxel treatment to 1.8 ns at two days after docetaxel treatment (Fig.3C, D). The observed increase<br />
in caspase-3 activity was not caused by insertion of the imaging window or by light exposure during<br />
imaging, since FLIM analysis of tumor sections from within the tumor (not reached by either the<br />
window or the laser beam) showed that FRET was even more frequently lost in these areas (Fig.S2A).<br />
Together, these data show that caspase-3 activity, and therefore the onset of apoptosis, is induced<br />
upon treatment with docetaxel both in vitro and in vivo.<br />
A In vitro B<br />
In vivo<br />
7<br />
6<br />
5<br />
4<br />
6<br />
SW480<br />
*<br />
*<br />
*<br />
3<br />
2<br />
4<br />
1<br />
2<br />
0<br />
-<br />
0<br />
+<br />
16<br />
+<br />
24<br />
+<br />
24*<br />
Docetaxel<br />
hours<br />
0<br />
Before Day1 Day2<br />
After Dtx<br />
C C26<br />
25mg/kg Dtx: D<br />
CFP/YFP ratio<br />
Increase in CFP-Fluoresc.<br />
Lifetime<br />
1.25 ns<br />
Alive<br />
2.5 ns<br />
Dead<br />
CFP/YFP ratio<br />
-<br />
+<br />
Fluorescence Lifetime (nsec)<br />
Figure 3. Docetaxel increases caspase-3 activity in vitro and in vivo<br />
A) Quantification of the CFP-YFP ratio of SW480 cells in vitro under indicated conditions. 24* indicates that only apoptotic cells<br />
were analyzed, in all other cases (0, 16, 24) mitotic cells were quantified. Apoptotic and mitotic cells were determined according<br />
to morphology. Apoptotic: membrane blebbing, fragmented DNA. Mitotic: condensed DNA, rounded membrane morphology.<br />
10 cells were quantified per condition. Average + SEM is shown. B) Quantification of CFP-YFP ratios in single cells in vivo of the<br />
same tumor fields before, 20 hours (day1) and 48 hours (day2) after 25mg/kg docetaxel treatment (SW480-left, C26-right).<br />
Representative experiment of 3 independent experiments per cell line is shown. One dot represents one cell. Line indicates average<br />
+ SD. n.s.: not-significant (student t-test, paired, P>0.05), *: significant (student t-test, unpaired, p0.05), *: significant (student<br />
t-test, unpaired, p